ABOUT AESTHER HEALTHCARE


Aesther Healthcare is a serial special purpose acquisition company (SPAC) or a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Its efficiency lies in getting start-up / smaller companies with great potential to go public successfully. The focus of Aesther Healthcare has always been to provide late-stage, high quality private core-sector companies an alternative to the tedious traditional IPO process, and assist in fostering their growth to the unicorn stage and beyond in the public market. Anywhere between 20-25% of the IPO market has been SPACs in the last four years. In the first few months of 2021, there have been 145 SPAC deals that have raised more than US $ 44.5 billion, according to data from SPAC Insider. Compare this with 55 traditional IPOs that raised US $ 21.7 billion so far this year.

The SPACs are booming if one goes by their growth and support received from the financial community. In 2020, despite the COVID pandemic, SPACs became a strong alternative path to liquidity, offering significant advantages such as shorter process duration, an ability to provide forward-looking financial projections, and immediate investment analyst attention. It is estimated that last year, technology SPACs had over $83 billion raised for 248 SPACs. Aesther Healthcare covers the entire process from the inception and the IPO of a SPAC vehicle, through searching for a business combination target, engaging with a prospective target with a Letter-of-Intent (LOI), executing a Definitive Agreement (DA), closing the business combination, and mentoring the combined entity to execute as a successful public growth company.





Investor Relations


SEC Filings

Read More >

Press Releases

Read More >

Media

Read More >

Share Price

Read More >








Core Competence Focus Sectors

Aesther Healthcare is identifying businesses primarily in the Pharmaceutical and Medical Devices & Health Technology sectors. We seek to enter into a business combination with a business that is well positioned to leverage the industry expertise, insights and relationships of the sponsor and our board of directors, and to create significant opportunities for value creation and improved financial performance.

The Pharmaceutical and Healthcare sectors have emerged and is currently in the public limelight and focus due to COVID pandemic. It is a space defined by intense capital requirements, regulatory challenges and a delayed entrance to the market. While institutional investors may see the above features as a barrier to entry and success on returns, Aesther Healthcare is confident that these are instead strong arguments for investment into the healthcare industry. Highly notable exits in the space have featured many successful companies developing novel treatments in rare disease, orphan drug populations and gene therapy. Our efforts are therefore on both - the Pharmaceutical (both innovative and generic drugs) and Medical-technology tech & Devices sectors.

Healthcare innovators and new businesses are in an eminent position to gain from public investments and become very large platforms that benefit millions of citizens by being part of the medicare system. Aesther Healthcare would like to partner with a company to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Our aim is to identify unicorns or companies with great potential, connect market-leaders and stakeholders together, remove friction, align stakeholder interests, and reward sustained, long-term performance.






Expertise and Experience


Aesther Healthcare and its Professional Team has been in the industry long enough to have in-house influence, knowledge or if need be access outside resources or investment to fuel growth and generate returns. Do get in touch for our proven track record that can deliver attractive returns to public market investors. We deliver capital appreciation as we invest only in those sectors in which we have broad spectrum expertise. We have a global network for sourcing resources, investments, clients, etc. all of which go into fueling growth and enhancing value. The slogan here is - Multiple Returns Through Smart Innovation and Use of Technology to Deliver Appreciation to All Stakeholders!





Aesther Healthcare is a serial special purpose acquisition company (SPAC) or a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

contact us

ftr icon

515 Madison Avenue,
Suite 8078, New York,
New York 10022

Investor Contact

CORE IR : 516 222 2560

www.coreir.com

Map


All Rights Reserved By Aesther Healthcare

Designed By Mirackle Solutions